Target intelligence / Profile preview

Orally Administered Drugs

01

Overview

Orally administered drugs are pharmaceuticals taken through the mouth, swallowed, and absorbed through the digestive tract, most often the small intestine[1][2][3][5][6]. This route is generally preferred for its non-invasiveness, convenience, safety, and cost-effectiveness, but presents challenges such as first-pass metabolism by the liver, variability in absorption due to food, stomach acidity, enzyme breakdown, and gastrointestinal irritation. The oral route is not an anatomical or biochemical target, but rather a method for drug delivery and absorption for systemic or local effects within the gastrointestinal tract[1][2][3][5][6].

Other names
Oral administrationOrally administered medicationPO drugsPer os medicationsSelf-administered oral drugs
02

Safety considerations

Altered absorption due to food, GI pH, or concurrent medicationsFirst-pass metabolism reducing drug bioavailabilityIrritation of gastrointestinal tract (e.g., aspirin, NSAIDs)Variable patient complianceUnsuitability for unconscious patients or those unable to swallowReduced/erratic absorption for some molecular classes

Beyond the preview

Go deeper on Orally Administered Drugs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orally Administered Drugs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call